A national quality improvement study identifying and addressing cancer screening deficits due to the COVID‐19 pandemic

RH Joung, H Nelson, TW Mullett, SH Kurtzman… - Cancer, 2022 - Wiley Online Library
Background Cancer‐related deaths over the next decade are expected to increase due to
cancer screening deficits associated with the coronavirus disease 2019 (COVID‐19) …

Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in “Back on track with …

M Fisher-Borne, J Isher-Witt, S Comstock… - Preventive medicine, 2021 - Elsevier
The COVID-19 pandemic has contributed to decreases in breast, colorectal, and cervical
cancer screenings between 86 and 94% compared to three-year averages. These …

[HTML][HTML] Impact of COVID-19 on screening rates for colorectal, breast, and cervical cancer: practice feedback from a quality improvement project in primary care

LA Schad, LA Brady, LM Tumiel-Berhalter… - Journal of Patient …, 2021 - ncbi.nlm.nih.gov
Purpose Three New York State practice-based research networks provided quality
improvement strategies to improve screening rates for breast, cervical, and colorectal (BCC) …

Association of cancer screening deficit in the United States with the COVID-19 pandemic

RC Chen, K Haynes, S Du, J Barron, AJ Katz - JAMA oncology, 2021 - jamanetwork.com
Importance The COVID-19 pandemic led to sharp declines in cancer screening. However,
the total deficit in screening in the US associated with the pandemic and the differential …

Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey

DMP Perin, KM Elfström, JL Bulliard, A Buron… - Preventive …, 2021 - Elsevier
Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-
19 pandemic led many countries to suspend cancer screening services as part of their …

[HTML][HTML] Reduction in standard cancer screening in 2020 throughout the US

LK Dennis, CH Hsu, AK Arrington - Cancers, 2021 - mdpi.com
Simple Summary The COVID-19 pandemic has had a significant impact on health care
including cancer screening. We examined 2020 compared to the 2014–2019 cancer …

[HTML][HTML] Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic

C Labaki, Z Bakouny, A Schmidt, SR Lipsitz… - Cancer Cell, 2021 - cell.com
Following the pandemic onset, a dramatic decrease in the number of cancer screening tests
and ensuing diagnoses was observed (Bakouny et al., 2021; Chen et al., 2021; Patt et al …

Cancer screening in the United States during the second year of the COVID-19 pandemic

J Star, P Bandi, RL Siegel, X Han, A Minihan… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To examine whether cancer screening prevalence in the United States during
2021 has returned to prepandemic levels using nationally representative data. METHODS …

Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: a provincial, population-based …

MJ Walker, O Meggetto, J Gao, G Espino-Hernández… - Preventive …, 2021 - Elsevier
It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening,
including for vulnerable sub-populations, to inform the development of evidence-based …

[HTML][HTML] Impact of the COVID-19 pandemic on colorectal and prostate cancer screening in a large US health system

AH Kelkar, J Zhao, S Wang, CR Cogle - Healthcare, 2022 - mdpi.com
During the first year of the coronavirus disease 2019 (COVID-19) pandemic, prevention
measures included quarantining and facility closures. Because cancer screening is …